HomeTrialNCT06674577
🔬NCT06674577Phase 2ENROLLING BY INVITATION

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Study Summary

The purpose of this study is to collect long-term safety and tolerability data for atacicept in patients with IgAN that completed Vera trial investigating atacicept in IgAN population.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment476 participants
Primary Completion
Lead SponsorVera Therapeutics, Inc.
Data Retrieved2026-04-11 04:30:54.036475+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.